Golden, Thanks @dachopper
I just wanted that to be crystal clear for everyone we are talking “annual” 2 Billion in sales for MSB’s first Ryoncil(Rem-L) therapy for Paeds and Adult aGVHD.
And this will be MSB’s smallest therapy use in the larger MSB plan. Full LBP and HF will be many many multiples of this revenue figure if/when Rex is approved.
As I said….Golden.
2024 Here we go again., page-525
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
-0.050(4.39%) |
Mkt cap ! $1.244B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.17 | $1.07 | $8.385M | 7.489M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8500 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 26954 | 3 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |